BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22890551)

  • 1. Elevated serum granulysin and its clinical relevance in mature NK-cell neoplasms.
    Sekiguchi N; Asano N; Ito T; Momose K; Momose M; Ishida F
    Int J Hematol; 2012 Oct; 96(4):461-8. PubMed ID: 22890551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
    Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
    Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulysin, a novel marker for extranodal NK/T cell lymphoma, nasal type.
    Lo Bello G; Akarca AU; Ambrosio MR; Agostinelli C; Molina-Kirsch H; Ramsay A; Rodriguez-Justo M; Pugh M; Zhao S; DeLisser M; Sabattini E; Dojcinov S; Pileri SA; Natkunam Y; Leoncini L; Marafioti T
    Virchows Arch; 2018 Dec; 473(6):749-757. PubMed ID: 30151671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
    Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
    Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type.
    Suzuki R; Suzumiya J; Yamaguchi M; Nakamura S; Kameoka J; Kojima H; Abe M; Kinoshita T; Yoshino T; Iwatsuki K; Kagami Y; Tsuzuki T; Kurokawa M; Ito K; Kawa K; Oshimi K;
    Ann Oncol; 2010 May; 21(5):1032-40. PubMed ID: 19850638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulysin in human serum as a marker of cell-mediated immunity.
    Ogawa K; Takamori Y; Suzuki K; Nagasawa M; Takano S; Kasahara Y; Nakamura Y; Kondo S; Sugamura K; Nakamura M; Nagata K
    Eur J Immunol; 2003 Jul; 33(7):1925-33. PubMed ID: 12884856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exhaustive exercise induces differential changes in serum granulysin and circulating number of natural killer cells.
    Zhang X; Matsuo K; Farmawati A; Higashi Y; Ogawa K; Nagata K; Nagatomi R
    Tohoku J Exp Med; 2006 Oct; 210(2):117-24. PubMed ID: 17023765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of granulysin and perforin by NK cells in cancer patients and correlation of impaired granulysin expression with progression of cancer.
    Kishi A; Takamori Y; Ogawa K; Takano S; Tomita S; Tanigawa M; Niman M; Kishida T; Fujita S
    Cancer Immunol Immunother; 2002 Jan; 50(11):604-14. PubMed ID: 11807624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dimethyl 2,2-dichlorovinyl phosphate (DDVP) markedly decreases the expression of perforin, granzyme A and granulysin in human NK-92CI cell line.
    Li Q; Nakadai A; Ishizaki M; Morimoto K; Ueda A; Krensky AM; Kawada T
    Toxicology; 2005 Sep; 213(1-2):107-16. PubMed ID: 16002202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum granulysin is a marker for Th1 type immunity in pre-eclampsia.
    Sakai M; Ogawa K; Shiozaki A; Yoneda S; Sasaki Y; Nagata K; Saito S
    Clin Exp Immunol; 2004 Apr; 136(1):114-9. PubMed ID: 15030522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased prevalence of peripheral blood granulysin-producing cytotoxic T lymphocytes in preeclampsia.
    Molvarec A; Shiozaki A; Ito M; Toldi G; Stenczer B; Szarka A; Nakashima A; Vásárhelyi B; Rigó J; Saito S
    J Reprod Immunol; 2011 Sep; 91(1-2):56-63. PubMed ID: 21763002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer-cell neoplasms.
    Greer JP; Mosse CA
    Curr Hematol Malig Rep; 2009 Oct; 4(4):245-52. PubMed ID: 20425414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extranodal NK/T-cell lymphoma of the nasal cavity developed in a patient with intestinal Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder.
    Furuya G; Abe H; Shinozaki-Ushiku A; Yamashita A; Ihara S; Hirata Y; Chiba A; Fujioka Y; Kurokawa M; Koike K; Fukayama M
    Pathol Res Pract; 2018 Jul; 214(7):1051-1055. PubMed ID: 29843925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Epstein-Barr virus-encoded proteins in extranodal NK/T-cell Lymphoma, nasal type (ENKL): differences in biologic and clinical behaviors of LMP1-positive and -negative ENKL.
    Kanemitsu N; Isobe Y; Masuda A; Momose S; Higashi M; Tamaru J; Sugimoto K; Komatsu N
    Clin Cancer Res; 2012 Apr; 18(8):2164-72. PubMed ID: 22371452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of advanced extranodal NK/T cell lymphoma, nasal-type and aggressive NK-cell leukemia.
    Suzuki R
    Int J Hematol; 2010 Dec; 92(5):697-701. PubMed ID: 21116747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The significance of peripheral blood natural killer cell surface CD
    Liu JX; Wang JW; Cui XY
    Zhonghua Nei Ke Za Zhi; 2016 Nov; 55(11):872-874. PubMed ID: 27801344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic mutations in
    Gao LM; Zhao S; Zhang WY; Wang M; Li HF; Lizaso A; Liu WP
    Cancer Biol Ther; 2019; 20(10):1319-1327. PubMed ID: 31311407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
    Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
    Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell neoplasm: biology and pathology.
    Ham MF; Ko YH
    Int J Hematol; 2010 Dec; 92(5):681-9. PubMed ID: 21132576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulysin as a novel factor for the prognosis of the clinical course of chickenpox.
    Baljic R; Gojak R; Konjo H; Hukic M
    Epidemiol Infect; 2018 May; 146(7):854-857. PubMed ID: 29633679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.